Learning Objectives:
•Discuss the myriad patient-specific factors that can add complexity to the use of diabetes technologies.
•Identify strategies to help patients with complex circumstances gain access to and develop the skills to successfully use beneficial diabetes technologies.
•Describe how diabetes technologies can improve glycemia and health outcomes—even for people with type 2 diabetes and complex circumstances.

Joseph Aloi, MD
Professor of Internal Medicine and
Chief of Endocrinology, Diabetes & Metabolism
Wake Forest School of Medicine
Winston-Salem, NC

Samar Hafida, MD
Staff Endocrinologist/ Adult Diabetes, Medical Weight Management Specialist
Clinical Instructor Harvard Medical School

Disclosures:
Dr. Aloi:
•Research support: Abbott Diabetes Care, Medtronic Diabetes
•Member, data safety monitoring board: Eupraxia

Dr. Hafida:
 None

Duration: 60 minutes